Sanofi Pasteur to develop COVID-19 vaccine with US governmen...

Sanofi Pasteur, the global vaccines business unit of the French drug maker Sanofi, has joined forces with a US government department to develop a novel COVID-19 coronavirus vaccine.

UK biotech OMass raises £27.5m for GPCR drug discovery

Castor gifts access to data platform for non-profit Covid-19...

Chiesi starts rare diseases division, ahead of potential Fab...

Italian pharma Chiesi has begun a new rare diseases division as it builds towards a potential commercial launch for its Fabry Disease therapy.

Blockbusters in waiting: drug launches to watch in 2020

Janssen trials ultrasound-guided approach to treating Crohn'...

In the highly competitive market for inflammatory diseases such as Crohn's, pharma companies are looking for ways to maximise benefits of already approved drugs, as well as